Breaking News Instant updates and real-time market news.

MYOK

MyoKardia

$50.45

2.15 (4.45%)

20:48
05/22/18
05/22
20:48
05/22/18
20:48

MyoKardia 3.75M share Secondary priced at $49.00

JPMorgan, BofA/Merrill, Credit Suisse and Wells Fargo acted as joint book running managers for the offering.

  • 23

    May

  • 23

    May

MYOK MyoKardia
$50.45

2.15 (4.45%)

04/13/18
WELS
04/13/18
NO CHANGE
Target $70
WELS
Outperform
MyoKardia price target raised to $70 from $56 at Wells Fargo
Wells Fargo analyst Jim Birchenough raised his price target for MyoKardia to $70 following his firm's non deal roadshow with senior management. The analyst came away with greater confidence in the prospects for Phase 3 success in hypertrophic cardiomyopathy. He reiterates an Outperform rating on MyoKardia shares.
03/12/18
COWN
03/12/18
NO CHANGE
Target $73
COWN
Outperform
MyoKardia price target raised to $73 from $56 at Cowen
Cowen analyst Ritu Baral raised her price target on MyoKardia to $73 from $56 following the presentation of its full data from the PIONEER-HCM Phase 2 trial's low-dose cohort B of mavacamten in oHCM patients. The presentation underscored the efficacy data as well as continued clean safety, said Baral, who reiterated her Outperform rating on MyoKardia shares.
03/09/18
FBCO
03/09/18
NO CHANGE
Target $68
FBCO
Outperform
MyoKardia price target raised to $68 from $60 at Credit Suisse
Credit Suisse analyst Martin Auster raised his price target on MyoKardia to $68 from $60, saying the company's update on its Phase 2 cohort B data for mavacamten for the treatment of obstructive hypertrophic cardiomyopathy was "just as we hoped." Auster views the news as a "meaningful" de-risking step supporting elevated conviction in the Phase 3 EXLORER study and believes the cohort B results should "incrementally increase" investors' long-term confidence in the mavacamten program. Auster, who has an Outperform rating on shares, added that MyoKardia is one of the most "promising" long-term stories in his coverage.
03/09/18
BMOC
03/09/18
NO CHANGE
Target $83
BMOC
Outperform
MyoKardia price target raised to $83 from $65 at BMO Capital
BMO Capital analyst M. Ian Somaiya raised his price target on MyoKardia to $83, saying the company's Phase 2 PIONEER Cohort-B results "significantly de-risked" EXPLORER Phase 3 trial by establishing a "safe and effective dose titration strategy that could allow physicians to individualize dosing of mavacamten to achieve peak VO2 and LVOT benefit". Somaiya keeps his Outperform rating on MyoKardia, adding that his new price target re-calibrates mavacamten's probability of success.

TODAY'S FREE FLY STORIES

BCS

Barclays

$8.50

0.1 (1.19%)

, JPM

JPMorgan

$102.72

-0.23 (-0.22%)

05:51
01/24/19
01/24
05:51
01/24/19
05:51
Periodicals
Barclays CEO: 'Likely' there will be another financial crisis, Bloomberg reports »

Barclays (BCS) CEO Jes…

BCS

Barclays

$8.50

0.1 (1.19%)

JPM

JPMorgan

$102.72

-0.23 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

CIOXY

Cielo

$0.00

(0.00%)

05:49
01/24/19
01/24
05:49
01/24/19
05:49
Upgrade
Cielo rating change  »

Cielo upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$153.91

0.61 (0.40%)

05:47
01/24/19
01/24
05:47
01/24/19
05:47
Periodicals
Apple dismisses over 200 people from autonomous vehicle group, CNBC reports »

Apple dismissed just over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

BANC

Banc of California

$14.94

0.09 (0.61%)

05:42
01/24/19
01/24
05:42
01/24/19
05:42
Earnings
Banc of California reports Q4 EPS 13c, consensus 23c »

Reports Q4 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

APDN

Applied DNA Sciences

$0.46

0.0243 (5.53%)

05:39
01/24/19
01/24
05:39
01/24/19
05:39
Hot Stocks
Applied DNA Sciences signs MOU with Sun Chemical Supply »

Applied DNA Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQ

iQIYI

$18.32

0.6 (3.39%)

, CTRP

Ctrip

$30.25

-0.65 (-2.10%)

05:37
01/24/19
01/24
05:37
01/24/19
05:37
Hot Stocks
iQIYI, Ctrip expand strategic cooperation in shared membership »

iQIYI (IQ) announced a…

IQ

iQIYI

$18.32

0.6 (3.39%)

CTRP

Ctrip

$30.25

-0.65 (-2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAL

TAL Education

$31.21

-0.01 (-0.03%)

05:35
01/24/19
01/24
05:35
01/24/19
05:35
Earnings
Breaking Earnings news story on TAL Education »

TAL Education sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

TAL

TAL Education

$31.21

-0.01 (-0.03%)

05:34
01/24/19
01/24
05:34
01/24/19
05:34
Earnings
TAL Education reports Q3 EPS ex-items 24c, may not compare to consensus 8c »

Reports Q3 revenue $589M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

EAF

GrafTech

$12.98

-0.49 (-3.64%)

05:33
01/24/19
01/24
05:33
01/24/19
05:33
Recommendations
GrafTech analyst commentary  »

Vertical Group sees 30%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

NIO

NIO Inc.

$6.54

-0.02 (-0.30%)

05:31
01/24/19
01/24
05:31
01/24/19
05:31
Hot Stocks
NIO Inc. CEO transferred 50M shares to newly-established NIO user trust »

NIO Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STM

STMicroelectronics

$14.10

0.06 (0.43%)

05:30
01/24/19
01/24
05:30
01/24/19
05:30
Earnings
Breaking Earnings news story on STMicroelectronics »

STMicroelectronics sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

IRWD

Ironwood

$12.41

-0.32 (-2.51%)

05:30
01/24/19
01/24
05:30
01/24/19
05:30
Upgrade
Ironwood rating change  »

Ironwood upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

STM

STMicroelectronics

$14.10

0.06 (0.43%)

05:29
01/24/19
01/24
05:29
01/24/19
05:29
Earnings
STMicroelectronics reports Q4 EPS 46c, consensus 44c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

FN

Fabrinet

$52.05

-1.86 (-3.45%)

05:24
01/24/19
01/24
05:24
01/24/19
05:24
Recommendations
Fabrinet analyst commentary  »

Fabrinet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

LITE

Lumentum

$46.00

0.83 (1.84%)

05:24
01/24/19
01/24
05:24
01/24/19
05:24
Recommendations
Lumentum analyst commentary  »

Lumentum price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

BMS

Bemis

$47.82

0.28 (0.59%)

05:17
01/24/19
01/24
05:17
01/24/19
05:17
Hot Stocks
Bemis, Amcor say closing delayed due to U.S. government shutdown »

Amcor and Bemis have made…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$64.09

2.08 (3.35%)

05:15
01/24/19
01/24
05:15
01/24/19
05:15
Recommendations
Tactile Systems analyst commentary  »

Piper more bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACIA

Acacia Communications

$42.07

0.93 (2.26%)

05:12
01/24/19
01/24
05:12
01/24/19
05:12
Recommendations
Acacia Communications analyst commentary  »

Acacia Q4 results to meet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

GKOS

Glaukos

$60.73

-0.42 (-0.69%)

, AGN

Allergan

$160.81

3.045 (1.93%)

05:09
01/24/19
01/24
05:09
01/24/19
05:09
Recommendations
Glaukos, Allergan analyst commentary  »

Piper values Glaukos…

GKOS

Glaukos

$60.73

-0.42 (-0.69%)

AGN

Allergan

$160.81

3.045 (1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 18

    May

  • 28

    May

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$263.42

0.37 (0.14%)

05:05
01/24/19
01/24
05:05
01/24/19
05:05
General news
President Trump delays State of the Union address due to shutdown »

President Trump said…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$263.42

0.37 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$52.25

-0.25 (-0.48%)

05:01
01/24/19
01/24
05:01
01/24/19
05:01
Downgrade
Weibo rating change  »

Weibo downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBGLY

Reckitt Benckiser

$0.00

(0.00%)

05:00
01/24/19
01/24
05:00
01/24/19
05:00
Downgrade
Reckitt Benckiser rating change  »

Reckitt Benckiser…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

ANIX

Anixa Biosciences

$4.52

0.11 (2.49%)

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
Anixa Biosciences to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
Stephens restaurants analyst to hold a luncheon »

Restaurants Analyst…

SMTX

SMTC Corp.

$5.57

0.14 (2.58%)

04:55
01/24/19
01/24
04:55
01/24/19
04:55
Conference/Events
SMTC Corp. management to meet with B. Riley FBR »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.